Presenting author:        Type the complete name    (Registration ID)

Co-authors:                      Type the complete name.         

                                               The co-authors are to be cited in order of their contribution to the study; main contributors should be listed first.

Abstract Submission Closes: 22thMarch 2024.

Note: Any changes in guidelines and deadlines will be updated on the website

Guidelines for Abstract Submission – Case Report/ Series

•     Abstracts should be submitted in English.

•     Abstracts that are submitted must NOT have been previously presented in any other conference or published in any journals.

•     Abstracts must be submitted on or before 22th March 2024. All abstracts must be submitted through the link provided.

•     Please go through the abstract template given at the end and follow the format carefully. Documents that do not comply to the guidelines will be        asked to revise.

•     Documents should reach before deadline.

•     The abstract should be submitted in the format of MS Word (.doc or .docx) document.

Title: Please be as brief as possible. Do not use abbreviations or acronyms in the title.

Name(s) of Authors(s):

Presenting author: Type the complete name (Registration ID)

Co-authors: Type the complete name. The co-authors are to be cited in order of their contribution to the study;         

                        main contributors should be listed first.

Please follow the structured format for your Abstract:

         Word Count: Limit the text to 300 words excluding Title and Author details.

         Font: Times New Roman, font size 12 with spacing 1.

         Please provide keywords (no more than 6 words). Keywords should be written in lowercase letters (not applicable to names/scientific names)             and should be separated with commas.

         Give expansion of abbreviations, acronyms when it first appears in brackets.

         Use subtitles to mark the parts of the abstract; It must contain.

Introduction - Describe the context of the case and explain its relevance and importance

o     Describe whether the case is unique. If not, does the case have an unusual diagnosis, prognosis, therapy, or harm? Is the case an unusual         presentation of a common condition? Or an unusual complication of a disease or management?

o     Describe the instructive or teaching points that add value to this case. Does it demonstrate a cost-effective approach to management or         alternative diagnostic/treatment strategy? Does it increase awareness of a rare condition? 

o     Describe the history, examination, and investigations adequately. Is the cause of the patient's illness clear-cut? What are other plausible         explanations?

o     Describe the treatments adequately. Have all available therapeutic options been considered? Are outcomes related to treatments? Include the         patient’s progress and outcome. 

Discussion – Discuss rationale for decisions that were made and the lesson from the case.

o     Report a literature review of other similar cases. Describe how this case is different from those previously reported.

o     Explain the rationale for reporting the case. What is unusual about the case? Does it challenge prevailing wisdom? 

o     In the future, could things be done differently in a similar case? 

•     Affiliation: Course, Batch, Institutions.

The abstracts which require modification for acceptance shall be intimated within 7 days of receipt. Notification of abstract status and detailed instructions will be given to the presenting author/corresponding author listed on the abstract by mail. The complete schedule of all abstract presentations will be finalized by 4th week of March 2024.

Presenting author must register for the conference and pay the appropriate registration fee. Only one person will be allowed to present. Presenting author will be given the certificate of presentation and other authors will be given participation certificate provided they register for the conference.

All abstracts must identify a corresponding author. All information will be sent to the corresponding author. It is his/her responsibility to communicate this information to any additional authors.

Abstract Submission Opens: 14th February 2024

Abstract Submission Closes: 22th March 2024.

Note: Any changes in guidelines and deadlines will be updated on the website